Clinical Trial Update: Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating oral NMRA-335140 versus placebo in adults with major depressive disorder has completed, per the ClinicalTrials.gov update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NMRA-335140

Snippet

Sponsor: Neumora Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED